Product Introduction
Mofecon S 360 is a specialized immunosuppressive medication designed to prevent organ rejection in patients who have undergone kidney, liver, or heart transplants. Its active ingredient, Mycophenolic acid, works by reducing immune system activity, ensuring the transplanted organ is not attacked by the body's immune defenses.
This medication is an integral part of a multi-drug regimen used in transplantation medicine. With its proven efficacy and tolerability, Mofecon S 360 is trusted by healthcare providers worldwide.
Uses of Mofecon S 360
Mofecon S 360 is primarily used for:
- Prevention of Organ Rejection – Supports graft survival in transplant recipients.
- Immunosuppressive Therapy – Reduces immune response to prevent graft rejection.
- Improved Long-term Outcomes – Enhances transplant success rates.
Mofecon S 360 is a key component in ensuring the longevity and functionality of transplanted organs.
Side Effects of Mofecon S 360
Common side effects of Mofecon S 360 may include:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Headache
Less Common Side Effects
Less frequent but more serious side effects may include:
- Increased susceptibility to infections
- Blood disorders
- Severe allergic reactions
- Liver function abnormalities
We are pleased to offer you this product.
Mofecon S 360 is a cornerstone in transplant medicine, offering reliable immune suppression under expert medical supervision. It has earned its place as a vital option for ensuring the success of organ transplants.
- Take as prescribed by your doctor, typically twice daily.
- Swallow tablets whole with a full glass of water.
- Avoid skipping doses to ensure consistent immune suppression.
Mofecon S 360 inhibits the proliferation of T and B lymphocytes by blocking the enzyme inosine monophosphate dehydrogenase (IMPDH). This action reduces the immune response and helps prevent organ rejection.
- Proven efficacy in preventing organ rejection.
- Well-tolerated in most patients.
- Supports long-term graft survival.
- Avoid pregnancy during treatment and for six weeks after discontinuation.
- Regularly monitor blood counts and liver function.
- Inform your doctor if you experience unusual bleeding or signs of infection.